
Aspen Neuroscience, Inc. (ASPE)
Last updated: 2026-11-11 02:19:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Aspen Neuroscience, Inc. (ASPE) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $12.86, with a market capitalization of $361.74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $11.20 to $14.90. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$361.74M | |
$12.65 | |
$14.90 | |
$11.20 | |
$12.40 | |
273.66K | |
492.38K | |
-- | |
$14.90 | |
$11.20 | |
-- | |
-- |
Aspen Neuroscience, Inc. (ASPE) Latest Closing Stock Price
Aspen Neuroscience, Inc. (ASPE) last closed at $12.40 as of 2026-11-10 23:26:00, unchanged from the previous close of $12.40.
During the latest regular trading session, ASPE traded between $11.20 and $14.90, with a volume of 273.66K shares. The closing price was near the lower end and near the middle of its 52-week range.
Aspen Neuroscience, Inc. (ASPE) 7-Day Stock Price Change
Over the past seven days, Aspen Neuroscience, Inc. (ASPE) moved from $14.89 to $12.86, representing a decline of 13.63% ($2.03).
The stock traded between $11.20 and $14.90 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 492.38 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
ASPE 52-Week Price Position
Position in Range: 44.9%
ASPE is currently trading at $12.86, placing it 44.9% of the way from its 52-week low of $11.20 to its 52-week high of $14.90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Aspen Neuroscience, Inc. (ASPE)?
Aspen Neuroscience Inc is a clinical-stage, regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to initially address neurodegenerative diseases with high unmet medical need. The company's flagship program, sasineprocel, is an investigational autologous iPSC-based therapy for Parkinson's disease designed to replace a patient's lost dopamine neurons with dopaminergic neuron precursor cells.
Aspen Neuroscience, Inc. Information
| Exchange | NASDAQ |
| Company Website |
How to Buy Aspen Neuroscience, Inc. (ASPE) Stock on MEXC
Eligible investors can buy real shares of Aspen Neuroscience, Inc. (ASPE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Aspen Neuroscience, Inc. (ASPE) stock price today?
2.Is ASPE stock going up or down today?
3.What is ASPE pre-market price?
4.What is ASPE after-hours price?
5.Is ASPE stock trading now?
6.Where does ASPE sit relative to its 52-week high and low?
7.What sector is Aspen Neuroscience, Inc. in?
8.What is Aspen Neuroscience, Inc.'s market capitalization and where is it listed?
9.How is ASPE valued in terms of P/E ratio and EPS?
10.Does Aspen Neuroscience, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ASPE Stock Calculator
Estimate the value between ASPE shares and USD.
ASPE Shares to USD
1.00 ASPE shares = 12.86 USD
Calculations are estimates based on the latest available price and are for reference only.


